Viewing Study NCT04387461


Ignite Creation Date: 2025-12-24 @ 11:58 AM
Ignite Modification Date: 2025-12-25 @ 12:06 PM
Study NCT ID: NCT04387461
Status: COMPLETED
Last Update Posted: 2024-09-25
First Post: 2020-05-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin
Sponsor: CG Oncology, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module